By precisely modifying molecular structures , we perturb key quantum chemical parameters (bond energy/ orbital/ electrostatic potential)，and triggers:
1.Metabolic pathway switching
2.Phase shift in membrane permeability
3.Reprogramming of target-binding modes
Ultimately, this enables structural remodeling and achieves leap-forward improvements in drug efficacy and pharmacokinetic properties.
An innovation-driven platform for precise, accelerated drug R&D. Intergrating analytics of 600+ approved drugs with AI, the platform has advanced 20+ pipeline programs into clinical development, demonstrating strong commercialization potential.
Core principles: Timely addressing clinical needs.
1.Led Compound Design；
2. Patent Applications for Small-Molecule Assets；
3. Preclinical Study Protocols；
4. Clinical Strategy Development；
5. Drug Discovery & Development Advisory；
6. Global Clinical Trial Consulting(MRCT).
1. Innovative Drugs Advisory
2. Modernization of Chinese Medicine
3. Proof of Concept (PoC)
4. Drug Reactivation
